Homeβ€ΊSearchβ€ΊJournal of Hematology and Oncology

Journal of Hematology and Oncology

BioMed Central Ltd Β· United Kingdom Β· Est. 1813

ISSN1756-8722eISSN1756-8722
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
100
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (4 more)+22
Total100
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
92
days submission β†’ published
measured Β· last 20 articles Β· accept 74d
6
weeks to publish Β· journal-reported
Fast Β· vs ~15 wk median
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
11.824
H-Indexi
226
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
6.04
Total Worksi
2,163
Total Citationsi
203,447
2yr Mean Citednessi
26.94
Open Impact Factor alternative

Aims & Scope

Subject areas: Hematology; Oncology; Cancer Research; Molecular Biology.

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1813
Annual Volume~ 124 articles / year
StatusActive (last: 2026)
Total Publications2,163
Publisher OrgBioMed Central
OA Since2007
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
Review Time~6 weeks
Acceptance Rateβ€”
OA LicenseCC BY, CC BY-NC-ND
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes
πŸ“¦ Long-term Preservation
British Library; Koninklijke BibliotheekCLOCKSSLOCKSSPorticoPMC

Think.Check.Submit Compliance

10/12 Β· 83%
βœ…
Do you know the journal / publisher?
BioMed Central Ltd
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1756-8722 / 1756-8722
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
βœ…
Peer review process documented?
Single-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
βœ…
Long-term digital preservation?
British Library; Koninklijke Bibliotheek, CLOCKSS, LOCKSS, Portico, PMC
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
145
27k
2019
174
30k
2020
206
26k
2021
178
21k
2022
123
9.2k
2023
132
6.6k
2024
118
2.6k
2025
54
37
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Cancer ResearchQ1
HematologyQ1
Molecular BiologyQ1
OncologyQ1

Subject Classification

Web of Science Categories

HematologyOncology

Scopus Categories

HematologyCancer ResearchOncologyMolecular Biology

Research Topics (OpenAlex)

CAR-T cell therapy researchAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionMultiple Myeloma Research and TreatmentsAcute Lymphoblastic Leukemia researchHematopoietic Stem Cell TransplantationCancer-related molecular mechanisms researchImmunotherapy and Immune Responses

Frequently asked questions about Journal of Hematology and Oncology

Is Journal of Hematology and Oncology a predatory journal?

PubScope has no integrity flags on record for Journal of Hematology and Oncology: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Journal of Hematology and Oncology?

Journal of Hematology and Oncology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 26.94.

Is Journal of Hematology and Oncology indexed in Scopus and Web of Science?

Journal of Hematology and Oncology is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Journal of Hematology and Oncology?

Subject areas: Hematology; Oncology; Cancer Research; Molecular Biology.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref